<DOC>
	<DOCNO>NCT02981446</DOCNO>
	<brief_summary>The purpose study investigate intraocular pressure-lowering effect safety DE-117 ophthalmic solution compare Latanoprost ophthalmic solution subject open angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>A Phase III Study Assessing Safety Efficacy DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution Subjects With OAG OHT</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patients open angle glaucoma ocular hypertension eye Patients risk progression visual field loss Patients severe visual field defect Patients diseases preclude participation study safety reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>